Back to Search
Start Over
Severe hyperprostaglandin E syndrome with hyperthyroidism--studies of pathogenetic mechanisms.
- Source :
-
Journal of inherited metabolic disease [J Inherit Metab Dis] 1996; Vol. 19 (5), pp. 687-94. - Publication Year :
- 1996
-
Abstract
- Hyperprostaglandin E syndrome is a rare disease usually presenting with renal symptoms such as polyuria, polyhydramnios, hypercalciuria, hypokalaemia, and recurrent episodes of extreme fever, diarrhoea, and convulsions. We report a severe variant of this syndrome with obvious pain and prostaglandin E2 (PGE2)-stimulated hyperthyroidism, an association not previously described. Urinary excretion of PGE2 and its metabolite 7 alpha-hydroxy-5,11-diketotetranorprosta-1,16-dioic acid were markedly increased above normal levels (to 53.3 and 1895 ng/h per 1.73 m2, respectively). We studied oxidative capacity of peroxisomes and mitochondria, the sites where PGE2 oxidation takes place. A generalized mitochondrial disease could be ruled out and no deficiency was found in liver peroxisomal oxidases. The basic pathology of hyperprostaglandin E syndrome remains unsolved.
- Subjects :
- Cyclooxygenase Inhibitors therapeutic use
Dinoprostone urine
Female
Humans
Hyperthyroidism drug therapy
Hyperthyroidism metabolism
Indomethacin therapeutic use
Infant
Infant, Newborn
Microbodies metabolism
Mitochondria, Muscle metabolism
Oxidation-Reduction
Syndrome
Dinoprostone metabolism
Hyperthyroidism etiology
Subjects
Details
- Language :
- English
- ISSN :
- 0141-8955
- Volume :
- 19
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Journal of inherited metabolic disease
- Publication Type :
- Academic Journal
- Accession number :
- 8892027
- Full Text :
- https://doi.org/10.1007/BF01799846